NCT06711952 · RECRUITING
German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)
This study is testing whether a self-reported questionnaire called the SCD-Q accurately measures how people perceive their own memory and thinking changes — in German-speaking patients. It is not a drug trial; it is a validation study, meaning researchers are checking whether this questionnaire is a reliable tool for German clinical settings. No phase designation applies because no treatment is being tested.
You may qualify if
- Medical appointment for dementia diagnostics at the Alzheimer Therapie- und Forschungszentrum
- Provision of signed, written and dated informed consent
- Capacity to give informed consent
You're excluded if
- dementia in a very advance stage
- Illiteracy
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-05-29